Aurora Historical Income Statement

ACB Stock

CAD 6.16 0.01 0.16%

Historical analysis of Aurora Cannabis income statement accounts such as Selling General Administrative of 66.4 M, Other Operating Expenses of 195 M or Ebitda of 21.5 M can show how well Aurora Cannabis performed in making a profits. Evaluating Aurora Cannabis income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Aurora Cannabis's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Aurora Cannabis latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aurora Cannabis is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurora Cannabis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Aurora Stock, please use our How to Invest in Aurora Cannabis guide.

About Aurora Income Statement Analysis

Aurora Cannabis Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Aurora Cannabis shareholders. The income statement also shows Aurora investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Aurora Cannabis Income Statement Chart

At this time, Aurora Cannabis' Interest Expense is very stable compared to the past year. As of the 24th of December 2024, EBITDA is likely to grow to about 21.5 M, while Selling General Administrative is likely to drop about 66.4 M.

Selling General Administrative Other Operating Expenses Total Operating Expenses Selling And Marketing Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Aurora Cannabis. It is also known as Aurora Cannabis overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Aurora Cannabis' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Aurora Cannabis current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurora Cannabis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Aurora Stock, please use our How to Invest in Aurora Cannabis guide.At this time, Aurora Cannabis' Interest Expense is very stable compared to the past year. As of the 24th of December 2024, EBITDA is likely to grow to about 21.5 M, while Selling General Administrative is likely to drop about 66.4 M.

Aurora Cannabis income statement Correlations

	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Ebit	Total Revenue	Gross Profit	Selling And Marketing Expenses	Income Before Tax	Total Other Income Expense Net	Net Income From Continuing Ops	Research Development	Cost Of Revenue	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Discontinued Operations	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.8	0.93	-0.92	-0.83	0.84	-0.82	-0.65	0.97	-0.9	0.85	-0.1	0.84	-0.82	-0.76	-0.83	0.89	0.9	-0.65	-0.64	-0.97	0.18	-0.7	0.98	-0.61
Selling General Administrative	0.8		0.91	-0.9	-0.83	0.99	-0.67	-0.74	0.9	-0.88	0.84	0.32	0.97	-0.68	-0.6	-0.62	0.92	0.66	-0.62	-0.75	-0.74	0.45	-0.63	0.88	-0.59
Other Operating Expenses	0.93	0.91		-0.97	-0.9	0.95	-0.75	-0.76	0.95	-0.94	0.94	0.06	0.96	-0.76	-0.68	-0.81	0.92	0.9	-0.68	-0.75	-0.9	0.3	-0.73	0.97	-0.64
Operating Income	-0.92	-0.9	-0.97		0.97	-0.94	0.81	0.83	-0.94	0.99	-0.82	0.09	-0.91	0.81	0.74	0.85	-0.96	-0.84	0.74	0.82	0.93	-0.36	0.76	-0.95	0.72
Ebitda	-0.83	-0.83	-0.9	0.97		-0.87	0.82	0.88	-0.83	0.99	-0.69	0.22	-0.82	0.82	0.76	0.88	-0.92	-0.75	0.77	0.87	0.88	-0.35	0.77	-0.86	0.76
Total Operating Expenses	0.84	0.99	0.95	-0.94	-0.87		-0.7	-0.76	0.92	-0.92	0.87	0.26	0.98	-0.7	-0.62	-0.69	0.93	0.73	-0.63	-0.76	-0.8	0.4	-0.65	0.92	-0.59
Net Income	-0.82	-0.67	-0.75	0.81	0.82	-0.7		0.83	-0.78	0.84	-0.58	0.25	-0.64	1.0	0.99	0.92	-0.88	-0.7	0.92	0.83	0.8	-0.11	0.91	-0.76	0.89
Income Tax Expense	-0.65	-0.74	-0.76	0.83	0.88	-0.76	0.83		-0.67	0.85	-0.56	0.15	-0.68	0.83	0.8	0.83	-0.88	-0.62	0.9	1.0	0.65	-0.11	0.88	-0.68	0.9
Depreciation And Amortization	0.97	0.9	0.95	-0.94	-0.83	0.92	-0.78	-0.67		-0.91	0.88	0.08	0.92	-0.78	-0.72	-0.75	0.93	0.84	-0.63	-0.67	-0.92	0.29	-0.67	0.99	-0.6
Ebit	-0.9	-0.88	-0.94	0.99	0.99	-0.92	0.84	0.85	-0.91		-0.77	0.14	-0.88	0.84	0.77	0.88	-0.95	-0.8	0.76	0.85	0.92	-0.34	0.77	-0.92	0.74
Total Revenue	0.85	0.84	0.94	-0.82	-0.69	0.87	-0.58	-0.56	0.88	-0.77		0.26	0.93	-0.58	-0.51	-0.65	0.78	0.89	-0.52	-0.55	-0.77	0.23	-0.6	0.9	-0.45
Gross Profit	-0.1	0.32	0.06	0.09	0.22	0.26	0.25	0.15	0.08	0.14	0.26		0.31	0.25	0.27	0.38	0.01	-0.15	0.23	0.13	0.27	0.17	0.21	0.03	0.28
Selling And Marketing Expenses	0.84	0.97	0.96	-0.91	-0.82	0.98	-0.64	-0.68	0.92	-0.88	0.93	0.31		-0.65	-0.57	-0.67	0.88	0.77	-0.57	-0.68	-0.79	0.38	-0.6	0.92	-0.51
Income Before Tax	-0.82	-0.68	-0.76	0.81	0.82	-0.7	1.0	0.83	-0.78	0.84	-0.58	0.25	-0.65		0.99	0.92	-0.89	-0.69	0.93	0.84	0.8	-0.11	0.92	-0.76	0.89
Total Other Income Expense Net	-0.76	-0.6	-0.68	0.74	0.76	-0.62	0.99	0.8	-0.72	0.77	-0.51	0.27	-0.57	0.99		0.89	-0.83	-0.64	0.93	0.81	0.73	-0.06	0.91	-0.69	0.89
Net Income From Continuing Ops	-0.83	-0.62	-0.81	0.85	0.88	-0.69	0.92	0.83	-0.75	0.88	-0.65	0.38	-0.67	0.92	0.89		-0.83	-0.83	0.86	0.81	0.87	-0.05	0.88	-0.79	0.8
Research Development	0.89	0.92	0.92	-0.96	-0.92	0.93	-0.88	-0.88	0.93	-0.95	0.78	0.01	0.88	-0.89	-0.83	-0.83		0.76	-0.83	-0.89	-0.84	0.29	-0.83	0.91	-0.82
Cost Of Revenue	0.9	0.66	0.9	-0.84	-0.75	0.73	-0.7	-0.62	0.84	-0.8	0.89	-0.15	0.77	-0.69	-0.64	-0.83	0.76		-0.65	-0.6	-0.87	0.11	-0.73	0.89	-0.58
Minority Interest	-0.65	-0.62	-0.68	0.74	0.77	-0.63	0.92	0.9	-0.63	0.76	-0.52	0.23	-0.57	0.93	0.93	0.86	-0.83	-0.65		0.91	0.62	-0.13	0.99	-0.62	0.98
Tax Provision	-0.64	-0.75	-0.75	0.82	0.87	-0.76	0.83	1.0	-0.67	0.85	-0.55	0.13	-0.68	0.84	0.81	0.81	-0.89	-0.6	0.91		0.63	-0.12	0.89	-0.67	0.91
Net Interest Income	-0.97	-0.74	-0.9	0.93	0.88	-0.8	0.8	0.65	-0.92	0.92	-0.77	0.27	-0.79	0.8	0.73	0.87	-0.84	-0.87	0.62	0.63		-0.23	0.65	-0.94	0.58
Interest Income	0.18	0.45	0.3	-0.36	-0.35	0.4	-0.11	-0.11	0.29	-0.34	0.23	0.17	0.38	-0.11	-0.06	-0.05	0.29	0.11	-0.13	-0.12	-0.23		-0.12	0.26	-0.19
Discontinued Operations	-0.7	-0.63	-0.73	0.76	0.77	-0.65	0.91	0.88	-0.67	0.77	-0.6	0.21	-0.6	0.92	0.91	0.88	-0.83	-0.73	0.99	0.89	0.65	-0.12		-0.67	0.96
Reconciled Depreciation	0.98	0.88	0.97	-0.95	-0.86	0.92	-0.76	-0.68	0.99	-0.92	0.9	0.03	0.92	-0.76	-0.69	-0.79	0.91	0.89	-0.62	-0.67	-0.94	0.26	-0.67		-0.58
Extraordinary Items	-0.61	-0.59	-0.64	0.72	0.76	-0.59	0.89	0.9	-0.6	0.74	-0.45	0.28	-0.51	0.89	0.89	0.8	-0.82	-0.58	0.98	0.91	0.58	-0.19	0.96	-0.58

Click cells to compare fundamentals

Aurora Cannabis Account Relationship Matchups

Aurora Cannabis income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	77.5M	66.4M	71.8M	39.5M	14.2M	19.2M
Selling General Administrative	265.2M	139.7M	127.0M	68.2M	104.9M	66.4M
Other Operating Expenses	763.4M	491.9M	440.7M	477.1M	297.4M	195.0M
Operating Income	(491.0M)	(282.8M)	(231.4M)	(245.5M)	(46.5M)	(48.8M)
Ebitda	(393.2M)	(137.2M)	(143.1M)	(203.3M)	20.5M	21.5M
Total Operating Expenses	450.9M	225.1M	240.6M	185.1M	158.5M	114.8M
Net Income	(3.3B)	(693.6M)	(1.7B)	(263.8M)	(69.3M)	(72.8M)
Income Tax Expense	(83.4M)	(6.3M)	(2.1M)	(20.2M)	(554K)	(581.7K)
Depreciation And Amortization	114.9M	98.1M	93.7M	42.2M	33.1M	31.3M
Ebit	(508.1M)	(235.3M)	(236.7M)	(245.5M)	(12.6M)	(13.2M)
Total Revenue	278.9M	245.3M	221.3M	231.6M	270.3M	143.9M
Gross Profit	(33.5M)	(21.6M)	21.2M	(60.4M)	131.5M	138.0M
Selling And Marketing Expenses	91.3M	55.2M	62.0M	52.0M	51.9M	33.3M
Income Before Tax	(3.4B)	(699.8M)	(1.7B)	(264.5M)	(59.6M)	(62.6M)
Total Other Income Expense Net	(2.8B)	(392.5M)	(1.4B)	(19.1M)	(31.1M)	(32.7M)
Net Income From Continuing Ops	(3.3B)	(693.5M)	(1.7B)	(1.8B)	(59.0M)	(62.0M)
Research Development	26.1M	11.4M	10.4M	5.0M	3.6M	3.4M
Cost Of Revenue	312.4M	266.8M	200.1M	292.0M	138.8M	131.2M
Net Income Applicable To Common Shares	(3.3B)	(693.6M)	(1.7B)	(199.0M)	(179.1M)	(188.1M)
Minority Interest	(24.4M)	1.5M	355K	2.1M	1.9M	1.9M
Tax Provision	(83.4M)	(6.3M)	(2.1M)	(15.2M)	(554K)	(581.7K)
Net Interest Income	(72.5M)	(60.7M)	(67.3M)	(51.5M)	(1.4M)	(1.4M)
Interest Income	56.6M	72.7M	4.5M	2.5M	12.8M	12.2M
Reconciled Depreciation	114.9M	98.1M	93.7M	65.2M	33.1M	31.4M

Pair Trading with Aurora Cannabis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aurora Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aurora Cannabis will appreciate offsetting losses from the drop in the long position's value.

Moving against Aurora Stock

0.9	ERE-UN	European Residential Real	Pair Corr
0.85	Y	Yellow Pages Limited	Pair Corr
0.84	FFH	Fairfax Financial	Pair Corr
0.83	FFH-PC	Fairfax Fin Hld	Pair Corr
0.82	NICU	Magna Mining	Pair Corr

The ability to find closely correlated positions to Aurora Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aurora Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aurora Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aurora Cannabis to buy it.

The correlation of Aurora Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aurora Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aurora Cannabis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aurora Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Aurora Cannabis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurora Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurora Cannabis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurora Cannabis Stock:

How To Invest In Aurora

Details

Is Aurora Stock a good investment?

Details

What is Aurora Cannabis' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Aurora Stock, please use our How to Invest in Aurora Cannabis guide.

You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Please note, there is a significant difference between Aurora Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurora Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurora Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aurora Historical Income Statement

About Aurora Income Statement Analysis

Aurora Cannabis Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Aurora Cannabis income statement Correlations

Aurora Cannabis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aurora Cannabis income statement Accounts

Pair Trading with Aurora Cannabis

Moving against Aurora Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 1.0	Net Income
Tax Provision	+ 1.0	Income Tax Expense
Total Operating Expenses	+ 0.99	Selling General Administrative
Ebit	+ 0.99	Operating Income
Ebit	+ 0.99	Ebitda
Total Other Income Expense Net	+ 0.99	Net Income

Operating Income	- 0.97	Other Operating Expenses
Net Interest Income	- 0.97	Interest Expense
Research Development	- 0.96	Operating Income
Research Development	- 0.95	Ebit
Reconciled Depreciation	- 0.95	Operating Income
Reconciled Depreciation	- 0.94	Net Interest Income